（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China へのコメント

（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China へのコメント /english/information/news/1538/ 株式会社ジーエヌアイグループ公式Webサイト Mon, 20 Feb 2023 13:23:10 +0000 hourly 1 https://wordpress.org/?v=6.5.5